These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 28945106)

  • 1. Development of a stated-preference instrument to prioritize treatment goals in recent onset schizophrenia.
    Beusterien K; Chan E; Such P; de Jong Laird A; Heres S; Amos K; Loze JY; Nylander AG; Robinson P; Bridges JFP
    Curr Med Res Opin; 2017 Dec; 33(12):2129-2136. PubMed ID: 28945106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantifying the treatment goals of people recently diagnosed with schizophrenia using best-worst scaling.
    Bridges JF; Beusterien K; Heres S; Such P; Sánchez-Covisa J; Nylander AG; Chan E; de Jong-Laird A
    Patient Prefer Adherence; 2018; 12():63-70. PubMed ID: 29379273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome Instrument.
    McCarrier KP; Atkinson TM; DeBusk KP; Liepa AM; Scanlon M; Coons SJ;
    Clin Ther; 2016 Apr; 38(4):794-810. PubMed ID: 27041408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient preferences for treating refractory overactive bladder in the UK.
    Hashim H; Beusterien K; Bridges JF; Amos K; Cardozo L
    Int Urol Nephrol; 2015 Oct; 47(10):1619-27. PubMed ID: 26347077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Australian Public Preferences for the Funding of New Health Technologies: A Comparison of Discrete Choice and Profile Case Best-Worst Scaling Methods.
    Whitty JA; Ratcliffe J; Chen G; Scuffham PA
    Med Decis Making; 2014 Jul; 34(5):638-54. PubMed ID: 24713695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of best-worst scaling to assess patient perceptions of treatments for refractory overactive bladder.
    Beusterien K; Kennelly MJ; Bridges JF; Amos K; Williams MJ; Vasavada S
    Neurourol Urodyn; 2016 Nov; 35(8):1028-1033. PubMed ID: 26370222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardization of the Maristán Scale of Informal Care in people with schizophrenia and other psychoses.
    Saldivia S; Torres-Gonzalez F; Runte-Geidel A; Xavier M; Grandon P; Antonioli C; Ballester D; Gibbons R; Melipillan R; Caldas JM; Vicente B; Galende E; King M
    Acta Psychiatr Scand; 2013 Dec; 128(6):468-74. PubMed ID: 23406584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying patient-relevant endpoints among individuals with schizophrenia: an application of patient-centered health technology assessment.
    Kinter ET; Schmeding A; Rudolph I; dosReis S; Bridges JF
    Int J Technol Assess Health Care; 2009 Jan; 25(1):35-41. PubMed ID: 19126249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient preferences for medicine administration for acute agitation: results from an internet-based survey of patients diagnosed with bipolar disorder or schizophrenia in two Nordic countries.
    Jørgensen TR; Emborg C; Dahlen K; Bøgelund M; Carlborg A
    Psychol Health Med; 2018 Jan; 23(1):30-38. PubMed ID: 28475360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-cultural adaptation of the Schizophrenia Caregiver Questionnaire (SCQ) and the Caregiver Global Impression (CaGI) Scales in 11 languages.
    Rofail D; Acquadro C; Izquierdo C; Regnault A; Zarit SH
    Health Qual Life Outcomes; 2015 Jun; 13():76. PubMed ID: 26050597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Centered Research to Support the Development of the Symptoms of Major Depressive Disorder Scale (SMDDS): Initial Qualitative Research.
    McCarrier KP; Deal LS; Abraham L; Blum SI; Bush EN; Martin ML; Thase ME; Coons SJ;
    Patient; 2016 Apr; 9(2):117-34. PubMed ID: 26113249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-relevant needs and treatment goals in nail psoriasis.
    Blome C; Costanzo A; Dauden E; Ferrandiz C; Girolomoni G; Gniadecki R; Iversen L; Menter A; Michaelis-Wittern K; Morita A; Nakagawa H; Reich K; Augustin M
    Qual Life Res; 2016 May; 25(5):1179-88. PubMed ID: 26433952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: results of a semi-quantitative survey.
    Bechini A; Falla A; Ahmad A; Veldhuijzen I; Boccalini S; Porchia B; Levi M
    BMC Infect Dis; 2015 Aug; 15():353. PubMed ID: 26286525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of a survey instrument for community health improvement.
    Bazos DA; Weeks WB; Fisher ES; DeBlois HA; Hamilton E; Young MJ
    Health Serv Res; 2001 Aug; 36(4):773-92. PubMed ID: 11508639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valuing Treatments for Parkinson Disease Incorporating Process Utility: Performance of Best-Worst Scaling, Time Trade-Off, and Visual Analogue Scales.
    Weernink MG; Groothuis-Oudshoorn CG; IJzerman MJ; van Til JA
    Value Health; 2016; 19(2):226-32. PubMed ID: 27021757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eliciting patient preferences, priorities and trade-offs for outcomes following kidney transplantation: a pilot best-worst scaling survey.
    Howell M; Wong G; Rose J; Tong A; Craig JC; Howard K
    BMJ Open; 2016 Jan; 6(1):e008163. PubMed ID: 26810994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To explore preferences and willingness to pay for attributes regarding stoma appliances amongst patients in the UK, France and Germany.
    Nafees B; Lloyd A; Elkin E; Porret T
    Curr Med Res Opin; 2015 Apr; 31(4):687-95. PubMed ID: 25651482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the Impact of Caring for a Person with Schizophrenia: Development of the Schizophrenia Caregiver Questionnaire.
    Gater A; Rofail D; Marshall C; Tolley C; Abetz-Webb L; Zarit SH; Berardo CG
    Patient; 2015 Dec; 8(6):507-20. PubMed ID: 25680337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using best-worst scaling choice experiments to measure public perceptions and preferences for healthcare reform in australia.
    Louviere JJ; Flynn TN
    Patient; 2010 Dec; 3(4):275-83. PubMed ID: 22273434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valuation and attainment of treatment goals in schizophrenia: perspectives of patients, relatives, physicians, and payers.
    Kuhnigk O; Slawik L; Meyer J; Naber D; Reimer J
    J Psychiatr Pract; 2012 Sep; 18(5):321-8. PubMed ID: 22995959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.